Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 (durvalumab) in patients with glioblastoma (GBM) Meeting Abstract
| Authors: | Reardon, D. A.; Kaley, T. J.; Dietrich, J.; Lim, M.; Dunn, G. P.; Gan, H. K.; Cloughesy, T. F.; Clarke, J. L.; Park, A. J.; Macri, M. J.; Ryan, A.; Ricciardi, T.; Reddy, V.; Venhaus, R. R. |
| Abstract Title: | Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 (durvalumab) in patients with glioblastoma (GBM) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 112s |
| Language: | English |
| ACCESSION: | WOS:000404665403067 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.TPS2080 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS2080 -- Source: Wos |
